Njeri Kamau
Njeri Kamau holds a joint PhD position in the Biostatistics unit of the Radboudumc
and at the Dutch Medicines Evaluation Board (MEB) in which her time is split between
performing research towards her PhD and working as a methodology assessor at the MEB.
She has a background in pharmacy and biostatistics and is doing research in the field
of early phase oncology clinical trials.
Specifically, her project focuses on the
application of model-based dose finding designs for targeted anti-cancer therapies
and the development of tools to improve on the use, uptake and regulatory advice
on these statistical designs. This is being done under the supervision of
Kit Roes, Steven Teerenstra and Mark van Bussel (MEB).
E: njeri.kamau - at - radboudumc.nl
